Please Wait.....
Report
Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Report I 2023-06-14 I 138 Pages I IMARC Group
The global generic injectables market size reached US$ 43.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 70.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.
A generic injectable is a drug formulated with the same active pharmaceutical ingredient as its branded counterpart in strength, dosage form, safety, performance, quality, intended use, side effects, and route of administration. It is as safe and effective as the innovator drug and is consequently used for administering the medication rapidly into the body. It facilitates the easy absorption of medicines in liquid form, which helps reduce the frequency of dosage administration without affecting the efficacy of the treatment. Besides this, it is cost-effective and does not require investment in testing, promotional activities, and research and development (R&D) compared to its branded counterparts. As a result, generic injectables are extensively utilized in treating cancer, diabetes, osteoporosis, osteoarthritis, rheumatoid arthritis, and respiratory, neurological, and cardiovascular disorders.
Generic Injectables Market Trends:
The growing global geriatric population, which is more susceptible to several chronic medical ailments, such as diabetes, cancer, and cardiovascular diseases, represents one of the key factors driving the demand for generic injectables worldwide. In addition, the rising occurrence of lifestyle disorders due to hectic schedules, changing dietary patterns, and sedentary lifestyles of individuals are positively influencing the market. Apart from this, initiatives undertaken by governing authorities of numerous countries to support key manufacturers and sellers are offering lucrative growth opportunities to manufacturers. This, along with the widespread adoption of advanced technologies in the manufacturing process of generic injectables, is propelling the market growth. Furthermore, the expansion of offline pharmacies, along with the easy availability of generic injectables via online pharmacies, is offering a favorable market outlook. The emerging trend of online shopping offers consumers a wide range of products, free doorstep delivery, exciting deals and discounts, and secured payment methods is anticipated to drive the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global generic injectables market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on therapeutic area, container, and distribution channel.
Breakup by Therapeutic Area:
Oncology
Anaesthesia
Anti-infectives
Parenteral Nutrition
Cardiovascular
The oncology segment currently dominates the market due to the increasing number of cancer patients.
Breakup by Container:
Vials
Ampoules
Premix
Prefilled Syringes
On the basis of the container, the market has been segmented into vials, ampoules, premix, and prefilled syringes.
Breakup by Distribution Channel:
Hospitals
Retail Pharmacy
Hospitals hold the largest market share due to the increasing cases of chronic medical disorders and the growing expansion of hospitals across the globe.
Regional Insights:
Europe
North America
Asia
Latin America
Middle East and Africa
North America enjoys the leading position in the market due to the existence of various leading manufacturers in the country.
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being
Hospira (Pfizer)
Fresenius Kabi
Hikma
Sandoz (Novartis)
Sagent
Sanofi
Baxter
This report provides a deep insight into the global generic injectables industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic injectables manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global generic injectables industry in any manner.
Key Questions Answered in This Report
1. What was the size of the global generic injectables market in 2022?
2. What is the expected growth rate of the global generic injectables market during 2023-2028?
3. What has been the impact of COVID-19 on the global generic injectables market?
4. What are the key factors driving the global generic injectables market?
5. What is the breakup of the global generic injectables market based on the therapeutic area?
6. What is the breakup of the global generic injectables market based on the distribution channel?
7. What are the key regions in the global generic injectables market?
8. Who are the key players/companies in the global generic injectables market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Region
5.4 Market Forecast
5.5 Major Players
6 Global Generic Drug Delivery Market
6.1 Oral
6.2 Injectables
6.3 Dermal/Topical
6.4 Inhalers
7 Global Generic Injectables Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Region
7.5 Market Breakup by Therapeutic Area
7.6 Market Breakup by Container
7.7 Market Breakup by Distribution Channel
7.8 Market Forecast
7.9 SWOT Analysis
7.9.1 Overview
7.9.2 Strengths
7.9.3 Weaknesses
7.9.4 Opportunities
7.9.5 Threats
7.10 Value Chain Analysis
7.11 Porter's Five Forces Analysis
7.11.1 Overview
7.11.2 Bargaining Power of Buyers
7.11.3 Bargaining Power of Suppliers
7.11.4 Degree of Competition
7.11.5 Threat of New Entrants
7.11.6 Threat of Substitutes
7.12 Key Market Drivers and Success Factors
8 Global Generic Injectables Market: Performance of Key Regions
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Latin America
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market by Therapeutic Area
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Anaesthesia
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Anti-infectives
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Parenteral Nutrition
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Cardiovascular
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market by Container
10.1 Vials
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Ampoules
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Premix
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Prefilled Syringes
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market by Distribution Channel
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Retail Pharmacy
11.2.1 Market Trends
11.2.2 Market Forecast
12 Global Generic Injectables Market: Competitive Landscape
12.1 Market Structure
12.2 Market Breakup by Key Players
13 Generic Injectables Manufacturing Process
13.1 Product Overview
13.2 Detailed Process Flow (Injectables)
13.3 Various Types of Unit Operations Involved
13.4 Mass Balance and Raw Material Requirements
14 Project Details, Requirements and Costs Involved
14.1 Land Requirements and Expenditures
14.2 Construction Requirements and Expenditures
14.3 Plant Machinery
14.4 Machinery Pictures
14.5 Raw Material Requirements and Expenditures
14.6 Packaging Requirements and Expenditures
14.7 Transportation Requirements and Expenditures
14.8 Utility Requirements and Expenditures
14.9 Manpower Requirements and Expenditures
14.10 Other Capital Investments
15 Loans and Financial Assistance
16 Project Economics
16.1 Capital Cost of the Project
16.2 Techno-Economic Parameters
16.3 Product Pricing and Margins Across Various Levels of the Supply Chain
16.4 Taxation and Depreciation
16.5 Income Projections
16.6 Expenditure Projections
16.7 Financial Analysis
16.8 Profit Analysis
17 Key Player Profiles
17.1 Hospira (Pfizer)
17.1.1 Company Overview
17.1.2 Product Portfolio
17.1.3 Financials
17.1.4 SWOT Analysis
17.2 Fresenius Kabi
17.2.1 Company Overview
17.2.2 Product Portfolio
17.2.3 Financials
17.2.4 SWOT Analysis
17.3 Hikma
17.3.1 Company Overview
17.3.2 Product Portfolio
17.3.3 Financials
17.3.4 SWOT Analysis
17.4 Sandoz (Novartis)
17.4.1 Company Overview
17.4.2 Product Portfolio
17.4.3 Financials
17.4.4 SWOT Analysis
17.5 Sagent
17.5.1 Company Overview
17.5.2 Product Portfolio
17.5.3 Financials
17.5.4 SWOT Analysis
17.6 Sanofi
17.6.1 Company Overview
17.6.2 Product Portfolio
17.6.3 Financials
17.6.4 SWOT Analysis
17.7 Baxter
17.7.1 Company Overview
17.7.2 Product Portfolio
17.7.3 Financials
17.7.4 SWOT Analysis
Figure 1: Global: Generic Drug Market: Value Trends (in Billion US$), 2017-2022
Figure 2: Global: Generic Drug Market: Breakup by Region (in %), 2022
Figure 3: Global: Generic Drug Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 4: Global: Generic Drug Delivery Market: Oral (in Million US$), 2017, 2022 & 2028
Figure 5: Global: Generic Drug Delivery Market: Injectables (in Million US$), 2017, 2022 & 2028
Figure 6: Global: Generic Drug Delivery Market: Dermal/Topical (in Million US$), 2017, 2022 & 2028
Figure 7: Global: Generic Drug Delivery Market: Inhalers (in Million US$), 2017, 2022 & 2028
Figure 8: Global: Generic Injectables Market: Value Trends (in Billion US$), 2017-2022
Figure 9: Global: Generic Injectables Market: Breakup by Region (in %), 2022
Figure 10: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2022
Figure 11: Global: Generic Injectables Market: Breakup by Container (in %), 2022
Figure 12: Global: Generic Injectables Market: Breakup by Distribution Channel (in %), 2022
Figure 13: Global: Generic Injectables Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 14: Global: Generic Injectables Industry: SWOT Analysis
Figure 15: Global: Generic Injectables Industry: Value Chain Analysis
Figure 16: Global: Generic Injectables Industry: Porter's Five Forces Analysis
Figure 17: North America: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 18: North America: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 19: Europe: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 20: Europe: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 21: Asia: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 22: Asia: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 23: Latin America: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 24: Latin America: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 25: Middle East and Africa: Generic Injectables Market (in Million US$), 2017 & 2022
Figure 26: Middle East and Africa: Generic Injectables Market Forecast (in Million US$), 2023-2028
Figure 27: Global: Generic Injectables (Oncology) Market: Value Trends (in Million US$), 2017 & 2022
Figure 28: Global: Generic Injectables (Oncology) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 29: Global: Generic Injectables (Anaesthesia) Market: Value Trends (in Million US$), 2017 & 2022
Figure 30: Global: Generic Injectables (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 31: Global: Generic Injectables (Anti-infectives) Market: Value Trends (in Million US$), 2017 & 2022
Figure 32: Global: Generic Injectables (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 33: Global: Generic Injectables (Parenteral Nutrition) Market: Value Trends (in Million US$), 2017 & 2022
Figure 34: Global: Generic Injectables (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 35: Global: Generic Injectables (Cardiovascular) Market: Value Trends (in Million US$), 2017 & 2022
Figure 36: Global: Generic Injectables (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 37: Global: Generic Injectables (Vials) Market: Value Trends (in Million US$), 2017 & 2022
Figure 38: Global: Generic Injectables (Vials) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 39: Global: Generic Injectables (Ampoules) Market: Value Trends (in Million US$), 2017 & 2022
Figure 40: Global: Generic Injectables (Ampoules) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 41: Global: Generic Injectables (Premix) Market: Value Trends (in Million US$), 2017 & 2022
Figure 42: Global: Generic Injectables (Premix) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 43: Global: Generic Injectables (Prefilled Syringes) Market: Value Trends (in Million US$), 2017 & 2022
Figure 44: Global: Generic Injectables (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2023-2028
Figure 45: Global: Generic Injectables Market: Sales through Hospitals (in Million US$), 2017 & 2022
Figure 46: Global: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2023-2028
Figure 47: Global: Generic Injectables Market: Sales through Retail Pharmacy (in Million US$), 2017 & 2022
Figure 48: Global: Generic Injectables Market Forecast: Sales through Retail Pharmacy (in Million US$), 2023-2028
Figure 49: Generic Injectables Manufacturing Process: Conversion Rate of Feedstocks
Figure 50: Generic Injectables Manufacturing: Detailed Process Flow
Figure 51: Generic Injectables Manufacturing: Production Cost Breakup (in %)
Figure 52: Generic Injectables Industry: Profit Margins at Various Levels of the Supply Chain
Figure 53: Generic Injectables Manufacturing Plant: Proposed Plant Layout
Figure 54: Generic Injectables Manufacturing Plant: Breakup of Capital Costs (in %)
Table 1: Global: Generic Drug Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2023-2028
Table 3: Global: Generic Drug Market: Revenues of Key Players (in Million US$), 2019
Table 4: Global: Generic Injectables Market: Key Industry Highlights, 2022 and 2028
Table 5: Global: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 7: Global: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2023-2028
Table 8: Global: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 9: Generic Injectables Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 10: Generic Injectables Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 11: Generic Injectables Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 12: Generic Injectables Manufacturing Plant: Raw Material Requirements (Kg/Day) and Expenditures (US$/Kg)
Table 13: Generic Injectables Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 14: Generic Injectables Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 15: Details of Financial Assistance Offered by Financial Institutions
Table 16: Generic Injectables Manufacturing Plant: Capital Costs (in US$)
Table 17: Generic Injectables Manufacturing Plant: Techno-Economic Parameters (in US$)
Table 18: Generic Injectables Manufacturing Plant: Taxation and Depreciation (in US$)
Table 19: Generic Injectables Manufacturing Plant: Income Projections (in US$)
Table 20: Generic Injectables Manufacturing Plant: Expenditure Projections (in US$)
Table 21: Generic Injectables Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 22: Generic Injectables Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 23: Generic Injectables Manufacturing Plant: Profit and Loss Account (in US$)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security